Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner

  • Authors:
    • Peng Zhao
    • Cunzu Wang
    • Zhen Fu
    • Yongping You
    • Yunxiang Cheng
    • Xiaoming Lu
    • Ailin Lu
    • Ning Liu
    • Peiyu Pu
    • Chunsheng Kang
    • Leif G. Salford
    • Xiaolong Fan
  • View Affiliations

  • Published online on: August 1, 2007     https://doi.org/10.3892/ijo.31.2.361
  • Pages: 361-368
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioma cells are characterized by their invasiveness and resistance against conventional therapeutics. Telomerase activity has been suggested to be an important target for glioma treatment. Here we assessed the anticancer effects and its potential mechanisms of lentiviral vector mediated siRNA knock-down of the human telomerase reverse transcriptase (hTERT) in U87MG human glioblastoma cells. Stable expression of anti-hTERT siRNA reduced the hTERT expression and TRAP assay telomerase activity to barely detectable levels. Injection of lentiviral vectors encoding anti-hTERT siRNA significantly inhibited the growth of pre-established macroscopic xenograft tumors, which was in contrast to the finding that no obvious effects on cell growth, cell cycle progression and telomere length were observed in anti-hTERT siRNA expressing U87MG cells during short-term in vitro cultures. The in vivo glioma growth inhibition effect was already evident in the period coincided with no detectable telomere length changes, suggesting that hTERT inhibition may hinder glioma cell growth in a telomere length-independent manner. Importantly, transwell migration assay showed profound inhibitory effect on the invasive capacity of U87MG cells following short-term anti-hTERT siRNA expression. Thus, efficient knock-down of hTERT can inhibit glioma cell proliferation and migration prior to its effect on telomere length.

Related Articles

Journal Cover

August 2007
Volume 31 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao P, Wang C, Fu Z, You Y, Cheng Y, Lu X, Lu A, Liu N, Pu P, Kang C, Kang C, et al: Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner. Int J Oncol 31: 361-368, 2007
APA
Zhao, P., Wang, C., Fu, Z., You, Y., Cheng, Y., Lu, X. ... Fan, X. (2007). Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner. International Journal of Oncology, 31, 361-368. https://doi.org/10.3892/ijo.31.2.361
MLA
Zhao, P., Wang, C., Fu, Z., You, Y., Cheng, Y., Lu, X., Lu, A., Liu, N., Pu, P., Kang, C., Salford, L. G., Fan, X."Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner". International Journal of Oncology 31.2 (2007): 361-368.
Chicago
Zhao, P., Wang, C., Fu, Z., You, Y., Cheng, Y., Lu, X., Lu, A., Liu, N., Pu, P., Kang, C., Salford, L. G., Fan, X."Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner". International Journal of Oncology 31, no. 2 (2007): 361-368. https://doi.org/10.3892/ijo.31.2.361